Treatment of limited disease small cell lung cancer: the multidisciplinary team

Publication

Treatment of limited disease small cell lung cancer: the multidisciplinary team

Journal Paper/Review - Aug 24, 2017

Glatzer Markus, Rittmeyer Achim, Müller Joachim, Opitz Isabelle, Papachristofilou Alexandros, Psallidas Ioannis, Früh Martin, Born Diana, Putora Paul Martin

Citation

Glatzer M, Rittmeyer A, Müller J, Opitz I, Papachristofilou A, Psallidas I, Früh M, Born D, Putora P. Treatment of limited disease small cell lung cancer: the multidisciplinary team. Eur Respir J. 2017; 50

Type

Journal Paper/Review (English)

Journal

Eur Respir J. 2017; 50

Publication Date

Aug 24, 2017

Issn Electronic

1399-3003

Brief description/objective

Small cell lung cancer (SCLC) presents multiple interdisciplinary challenges with several paradigm shifts in its treatment in recent years. SCLC treatment requires multidisciplinary management and timely treatment. The aim of this review is to focus on the team management aspects in the treatment of limited disease SCLC and how this can contribute towards improving outcomes.